GlycoMimetics Inc Investor Relations Material

GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. The company's primary focus is on developing a pipeline of product candidates in collaboration with The University of Florida and the National Institute of Health.